Startseite Analytical and Clinical Evaluation of Troponin I Determination on Dimension RXL-HM
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Analytical and Clinical Evaluation of Troponin I Determination on Dimension RXL-HM

  • Gerd Hafner , Dirk Peetz , Francesco Dati , Felix Post , Stefan Blankenberg , Ali A. Peivandi , Bernd Sucké , Hans-Jürgen Rupprecht , Manfred Dahm , Reiner von Kleist und Winfried Prellwitz
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 38 Heft 4

Abstract

The evaluation of cardiac troponin I (cTnI) on the Dimension RxL®-HM analyzer is presented. The one-step enzyme immunoassay is based on two cTnI specific monoclonal antibodies. Performed on a separate module of the analyzer, assay-time is 17 minutes. Using as criterion a between-run impression CV <20% the functional limit of detection was set at 0.1 μg/l. Cutoff level for minor myocardial damage of 0.1 μg/l was found. In Duchenne's dystrophy, patients showed increased cardiac Troponin T (cTnT) but no increased cTnI. In patients with a history of coronary heart disease undergoing chronic hemodialysis, cTnT and cTnI were increased. In different patients with submassive pulmonary embolism, increased cTnI was determined. In coronary artery bypass surgery without perioperative myocardial infarction, patients with extracorporeal circulation showed significantly higher cTnI at 24 h after surgery than those with minimal cardiac surgery. In patients with unstable angina, increased cTnI was found more often than on Stratus analyzer. In conclusion, the new assay is a very sensitive cTnI assay, fast and easy to perform in parallel to enzyme and substrate assays.

:
Published Online: 2005-06-01
Published in Print: 2000-04-30

Copyright © 2000 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. The Clinical Usefulness of the Measurement of Cytokines
  2. Measurement of Cholesterol and other Lipoprotein Constituents in the Clinical Laboratory
  3. Serum ras (p21) as a Marker for Occupationally Derived Lung Cancer?
  4. Macro Lactate Dehydrogenase in a Patient with Myocarditis
  5. Elimination of Serum Complexed Prostate-Specific Antigen after Radical Retropubic Prostatectomy
  6. Suitability of Collection Tubes with Separator Gels for Collecting and Storing Blood Samples for Therapeutic Drug Monitoring (TDM)
  7. Influence of in vivo Hemoglobin Carbamylation on HbA1c Measurements by Various Methods
  8. Comparison of the Abbott IMx® and a High-Performance Liquid Chromatography Method for Measuring Total Plasma Homocysteine
  9. Evaluation of the ADVIA® Centaur™ TSH-3 Assay
  10. Biochemical Composition and Electrolyte Balance of "Unstimulated" Whole Human Saliva
  11. Evaluation of a New Simple and Rapid Enzyme-Linked Immunosorbent Assay Kit for Neopterin Determination
  12. Analytical and Clinical Evaluation of Troponin I Determination on Dimension RXL-HM
  13. Use of Ion-Selective Electrodes for Blood-Electrolyte Analysis. Recommendations for Nomenclature, Definitions and Conventions
  14. FESCC Survey on Accreditation and Post-Graduate Training in Clinical Chemistry in European Countries
  15. Clinical Use of Soluble Transferrin Receptor
  16. Macro Creatine Kinase Type 1: a Clinically Significant Marker?
  17. Vitamin B12 and B12-Proteins. By Bernhard Kräutler, Duilio Arigoni and Bernard T. Golding, editors
  18. The Bone and Mineral Manual – a Practical Guide. By Michael Kleerekoper, Ethel Sins, Michael McClung, editors
Heruntergeladen am 11.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2000.051/html
Button zum nach oben scrollen